Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Gastroenterol Clin North Am ; 38(2): 245-65, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19446257

RESUMEN

Increased knowledge of risk factors and improved ICU care has decreased the incidence of stress-related bleeding. Not all critically ill patients need prophylaxis for SRMD and withholding such prophylaxis in suitable low-risk candidates is a reasonable and cost-effective approach. Mechanical ventilation for more than 48 hours and coagulopathy are the main risk factors for stress-induced upper GI bleeding. Although intravenous H2RAs can prevent clinically important bleeding, their benefits seem to be limited by the rapid development of tolerance. The availability of intravenous formulations of PPIs makes it possible to critically compare their prophylactic efficacy and safety to different classes of acid-suppressive agents, such as H2RAs, in critically ill patients. The appropriate dose of PPI and the role of newer PPI formulations need to be further defined along with proposed guidelines for the use of intravenous and oral/enteral formulations of PPIs in patients at risk for stress-related mucosal damage.


Asunto(s)
Hemorragia Gastrointestinal , Úlcera Gástrica/complicaciones , Estrés Fisiológico , Estrés Psicológico , Enfermedad Crítica , Mucosa Gástrica/patología , Hemorragia Gastrointestinal/tratamiento farmacológico , Hemorragia Gastrointestinal/epidemiología , Hemorragia Gastrointestinal/patología , Hemorragia Gastrointestinal/prevención & control , Antagonistas de los Receptores Histamínicos/uso terapéutico , Humanos , Inhibidores de la Bomba de Protones/uso terapéutico , Factores de Riesgo
3.
Dig Dis Sci ; 54(4): 758-66, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18716872

RESUMEN

The aim of the present studies was to examine mechanisms by which the rectally administered combination of N-acetylcysteine (NAC) plus mesalamine (5-ASA) affects inducers of inflammation to promote mucosal healing and reduce tissue inflammation in chemically (trinitrobenzene sulfonic acid, TNBS) induced colitis in rats. Experimental findings demonstrate that dual therapy with NAC plus 5-ASA was superior to individual agents in reducing histological measures of colitis. NAC alone and in combination with 5-ASA suppressed COX2 gene expression and prostaglandin E(2) (PGE(2)) levels to control values. Furthermore, NAC plus 5-ASA reduced nitrate generation, an expression of inducible nitric oxide synthase (iNOS) activity, to basal levels and these results were significantly lower than those observed with either NAC or 5-ASA alone. In conclusion, these results indicate that NAC plus 5-ASA exerts therapeutic benefit, in part by countering the actions of PGE(2) and the deleterious effects of oxidative and nitrosative stress induced by TNBS colitis.


Asunto(s)
Acetilcisteína/uso terapéutico , Colitis/tratamiento farmacológico , Dinoprostona/biosíntesis , Mesalamina/uso terapéutico , Óxido Nítrico/biosíntesis , Acetilcisteína/farmacología , Animales , Antiinflamatorios no Esteroideos/farmacología , Antiinflamatorios no Esteroideos/uso terapéutico , Colitis/inducido químicamente , Colitis/metabolismo , Colitis/patología , Colon/enzimología , Colon/patología , Ciclooxigenasa 1/metabolismo , Ciclooxigenasa 2/metabolismo , Quimioterapia Combinada , Depuradores de Radicales Libres/farmacología , Depuradores de Radicales Libres/uso terapéutico , Mucosa Intestinal/patología , Masculino , Proteínas de la Membrana/metabolismo , Mesalamina/farmacología , Óxido Nítrico Sintasa de Tipo II/metabolismo , Estrés Oxidativo , Ratas , Ratas Sprague-Dawley , Ácido Trinitrobencenosulfónico
4.
Exp Biol Med (Maywood) ; 233(10): 1301-8, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18703751

RESUMEN

UNLABELLED: Previous experiments in rats with chemically induced colitis have shown that the antioxidant N-acetylcysteine plus mesalamine (5-ASA) exerted a significantly greater therapeutic effect in promoting mucosal healing when compared to either agent alone. The aims of the present study were to compare the effects of three antioxidants plus mesalamine vs. 5-ASA alone in treatment of colitis induced by trinitrobenzene sulfonic acid (TNBS) in rats. METHODS: Three days following induction of TNBS colitis, rats received 8 days of rectal therapy with 5-ASA, or 5-ASA plus vitamin C (ascorbic acid), 5-ASA plus phenyl butylnitrone (PBN) and 5-ASA plus vitamin E (alpha-tocopherol). Distal colonic tissues were examined for microscopic colitis and myeloperoxidase (MPO) activity. RESULTS: Global assessments of microscopic colitis induced by TNBS indicated that 5-ASA alone significantly changed colonic injury by -31%. Combination therapy with ascorbic acid plus 5-ASA or alpha-tocopherol plus 5-ASA caused further significant change in TNBS colitis by -65 and -82%, respectively. Each of these values was significantly below scores observed with 5-ASA as monotherapy. Reduction in colitis with PBN plus 5-ASA was not different from 5-ASA alone. MPO activity was decreased significantly in response to monotherapy with 5-ASA and each of the antioxidants plus 5-ASA when compared to TNBS. alpha-Tocopherol plus 5-ASA, however, was the only treatment strategy that reduced significantly MPO activity below that recorded for 5-ASA alone. In conclusion, our results indicate that antioxidants other than N-acetylcysteine significantly enhance the therapeutic effectiveness of 5-ASA in the treatment of TNBS colitis. alpha-Tocopherol plus 5-ASA exerted profound anti-inflammatory and reparative effects upon colitis induced by TNBS.


Asunto(s)
Antioxidantes/uso terapéutico , Colitis/tratamiento farmacológico , Colitis/patología , Mesalamina/uso terapéutico , Animales , Antioxidantes/farmacología , Ácido Ascórbico/farmacología , Ácido Ascórbico/uso terapéutico , Colitis/inducido químicamente , Óxidos N-Cíclicos/farmacología , Óxidos N-Cíclicos/uso terapéutico , Modelos Animales de Enfermedad , Sinergismo Farmacológico , Quimioterapia Combinada , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/patología , Masculino , Mesalamina/farmacología , Ratas , Ratas Sprague-Dawley , Ácido Trinitrobencenosulfónico , Vitamina E/farmacología , Vitamina E/uso terapéutico
5.
J Okla State Med Assoc ; 101(2): 35-7, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18361032

RESUMEN

Gastrointestinal stromal tumor (GIST) is a submucosal tumor which is most commonly found in the stomach and less commonly in small bowel. Small bowel GIST can be difficult to diagnose by conventional imaging and endoscopy techniques. We report a case of obscure GI bleeding due to a stromal tumor (GIST) of the jejunum diagnosed by video capsule endoscopy.


Asunto(s)
Endoscopía Capsular , Hemorragia Gastrointestinal/etiología , Tumores del Estroma Gastrointestinal/diagnóstico , Neoplasias del Yeyuno/diagnóstico , Anciano de 80 o más Años , Hemorragia Gastrointestinal/diagnóstico , Tumores del Estroma Gastrointestinal/complicaciones , Tumores del Estroma Gastrointestinal/fisiopatología , Humanos , Neoplasias del Yeyuno/complicaciones , Neoplasias del Yeyuno/fisiopatología , Masculino
7.
Int J Biochem Cell Biol ; 39(11): 2143-52, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17656145

RESUMEN

BACKGROUND AND AIMS: GPCR stimulation by various ligands including histamine has been shown to transactivate the epidermal growth factor receptor (EGFR). This study examines the functional interactions between the H2 receptor and the EGFR in the regulation of matrix metalloproteinase-1 (MMP-1) secretion and gene expressions in cultured gastric epithelial cells. METHODS: AGS cells were incubated for up to 24 h with either histamine or heparin binding-epidermal growth factor (HB-EGF) and MMP-1 release was determined by immunoassay. MMP-1 responses to histamine and HB-EGF were further tested by the use of H2 receptor antagonist, EGFR inhibitor and mitogen activator protein kinase (MAPK) inhibitor. The role of EGFR in MMP-1 release was further tested in cells transfected with specific EGFR siRNA. EGFR and ERK1/2 phosphorylation was determined by Western blot analysis. MMP-1 gene expression was determined by RNase protection assay (RPA). RESULTS: Histamine and HB-EGF caused a dose-dependent release of MMP-1 with maximal responses that were 2.7- and 4.5-fold greater, respectively, than control, P<0.001. Famotidine prevented histamine-mediated MMP-1 release and AG1478 and EGFR siRNA completely inhibited MMP-1 secretion stimulated by both histamine and HB-EGF. Both histamine and HB-EGF stimulation of MMP-1 release was associated with activation of ERK1/2. MAPK inhibition also prevented histamine-and HB-EGF-induced MMP-1 secretion. Results of MMP-1 gene expression, either stimulatory or inhibitory, paralleled responses to MMP-1 secretion. CONCLUSION: Histamine stimulation of the H2 receptor on AGS cells evoked MMP-1 secretion and gene up regulation that was dependent on transactivation of the EGFR and downstream activation of MAPK.


Asunto(s)
Colagenasas/genética , Colagenasas/metabolismo , Células Epiteliales/efectos de los fármacos , Receptores ErbB/genética , Histamina/farmacología , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Estómago/citología , Células Epiteliales/citología , Células Epiteliales/enzimología , Células Epiteliales/metabolismo , Receptores ErbB/antagonistas & inhibidores , Famotidina/farmacología , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Factor de Crecimiento Similar a EGF de Unión a Heparina , Humanos , Péptidos y Proteínas de Señalización Intercelular/farmacología , Proteína Quinasa 1 Activada por Mitógenos/antagonistas & inhibidores , Proteína Quinasa 3 Activada por Mitógenos/antagonistas & inhibidores , Inhibidores de Proteínas Quinasas/farmacología , Quinazolinas , ARN Interferente Pequeño/farmacología , Estómago/efectos de los fármacos , Estómago/enzimología , Factores de Tiempo , Activación Transcripcional/efectos de los fármacos , Activación Transcripcional/genética , Tirfostinos/farmacología
8.
South Med J ; 100(3): 281-6, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17396732

RESUMEN

Gastroparesis is a symptomatic disorder of the stomach characterized by slow or delayed gastric emptying. Diabetes and idiopathic factors account for over 60% of gastroparesis cases. Symptoms associated with delayed gastric emptying include nausea, vomiting, abdominal bloating and early satiety. Delayed gastric emptying due to gastroparesis is managed by dietary adjustments, prokinetic medications, avoidance of medications that retard gastric motor activity and optimizing glycemic control in diabetic patients. Electrical stimulation and gastric pacing are an evolving treatment option for patients who do not respond to standard medical therapy. This article provides a review of gastric motility, the etiologies of gastroparesis and therapeutic approaches to this disorder.


Asunto(s)
Gastroparesia , Terapia por Estimulación Eléctrica , Vaciamiento Gástrico/fisiología , Fármacos Gastrointestinales/uso terapéutico , Gastroparesia/diagnóstico , Gastroparesia/etiología , Gastroparesia/terapia , Humanos , Complejo Mioeléctrico Migratorio/fisiología
10.
Dig Dis Sci ; 51(4): 698-705, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16614991

RESUMEN

The aims of this study were to examine the ability of the antioxidant N-acetylcysteine (NAC) and mesalamine (5-ASA) alone and in combination to affect TNBS-induced colitis in rat. Three days following induction of TNBS colitis rats were randomized to receive daily intracolonic treatment with NAC, 5-ASA, and NAC plus 5-ASA for 5 or 8 days. At the end of the treatment period macroscopic and microscopic colonic injuries were scored. Myeloperoxidase (MPO) activity and cytokine gene expression were measured in colonic tissues. Results indicated that treatment with NAC plus 5-ASA caused a significantly greater reduction in colonic injury than either agent alone. Furthermore, combination therapy inhibited significantly MPO activity and inflammatory cytokine gene expression in the distal colon of TNBS-treated animals. The beneficial effects of NAC plus 5-ASA on reduction of colonic injury and promotion of healing were most evident after 8 days of treatment.


Asunto(s)
Acetilcisteína/farmacología , Antiinflamatorios no Esteroideos/farmacología , Colitis/tratamiento farmacológico , Mesalamina/farmacología , Animales , Antioxidantes/farmacología , Biopsia con Aguja , Colitis/patología , Citocinas/análisis , Citocinas/metabolismo , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Quimioterapia Combinada , Inmunohistoquímica , Mediadores de Inflamación/análisis , Masculino , Peroxidasa/efectos de los fármacos , Peroxidasa/metabolismo , Probabilidad , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Valores de Referencia , Sensibilidad y Especificidad
11.
Dig Dis Sci ; 51(2): 274-81, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16534669

RESUMEN

Epidermal growth factor (EGF) and transforming growth factor alpha (TGFalpha) have been shown to inhibit gastric acid secretion through stimulation of the EGF receptor (EGFR). In this study we examined in vivo the effects of inhibition of the EGFR on histamine-stimulated acid secretion in the rat. Submaximal (1.5 mg/kg/hr) histamine-stimulated acid secretion was measured (microEq H(+)/2 hr) during infusion of EGFRtk inhibitors and ranitidine in anesthetized rats. EGFR phosphorylation in gastric mucosal tissue lysates was measured by Western blot analysis. Submaximal histamine-stimulated acid secretion was increased significantly by the EGFR inhibitors tyrphostin (Tyr) A46 and Tyr AG1478. Tyr A46 prevented TGFalpha (10 microg/kg/hr)-mediated inhibition of maximal (5.0 microg/kg/hr) histamine-stimulated acid output. Histamine caused a fourfold increase in EGFR phosphorylation which was inhibited by both Tyr and ranitidine. We conclude that the EGFRtk inhibitors, Tyr A46 and Tyr AG1478, significantly increased submaximal histamine-stimulated acid output and Tyr A46 prevented TGFalpha inhibition of histamine-stimulated acid secretion. These observations suggest that the EGFR is involved, in vivo, in the regulation of gastric acid secretion.


Asunto(s)
Receptores ErbB/antagonistas & inhibidores , Receptores ErbB/fisiología , Ácido Gástrico/metabolismo , Tirfostinos/farmacología , Animales , Histamina , Antagonistas de los Receptores H2 de la Histamina/farmacología , Masculino , Fosforilación/efectos de los fármacos , Quinazolinas , Ranitidina/farmacología , Ratas , Ratas Sprague-Dawley , Factor de Crecimiento Transformador alfa/fisiología
12.
Curr Treat Options Gastroenterol ; 9(2): 157-66, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16539876

RESUMEN

Although upper gastrointestinal (GI) bleeding from stress-related mucosal disease (SRMD) in critically ill patients is common, significant bleeding with hemodynamic instability is not. Risk factor assessment can assist in identifying patients with a greater likelihood of developing significant SRMD. Prophylaxis against stress ulcer bleeding with luminal agents (eg, antacids and sucralfate) or drugs that inhibit acid secretion (eg, histamine 2-receptor antagonists and proton-pump inhibitors) can reduce major bleeding but has little or no effect on mortality. Currently, the mainstays of prophylactic therapy for SRMD are intravenously administered H2RAs and PPIs. Wider usage of PPIs reflects their enhanced efficacy in suppressing acid secretion as well as lack of tolerance for H2RAs. Guidelines for the prophylactic use of H2RAs or PPIs in treatment of SRMD will require large, randomized studies that also examine cost effectiveness of individual strategies.

13.
Gastrointest Endosc ; 62(6): 886-91, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16301032

RESUMEN

BACKGROUND: Colonic hamartomas are uncommon in adults. The aims of this study were to determine (1) the prevalence of colonic hamartomas in an adult population undergoing colonoscopy and (2) the clinical, endoscopic, and histologic features of colonic hamartomas in adult patients. METHODS: A pathology database identified 19 adult patients of 12,707 patients with colonic hamartomas in the 11-year study period from January 1992 to October 2002. An endoscopic computer database provided information about the number of colonoscopies performed and the presence or the absence of colonic polyp(s) in study patients. Charts of patients with colonic hamartomas were reviewed, and clinical and demographic data were collated. RESULTS: Nineteen patients were found to have colonic hamartomas. The mean age of these patients was 55 years, with an age distribution ranging from 25 to 81 years. The prevalence of colonic hamartomas in this study population was 0.15%. The prevalence of hamartomas in patients with colon polyps at index colonoscopy was 0.073%. Colonic hamartomas were more common in men than in women. The indication for colonoscopy for the majority (68%) of patients was hematochezia or the presence of occult blood in the stool. Three fourths of the polyps were greater than 1 cm in diameter, and 89% were pedunculated. Two thirds of the hamartomatous polyps were localized to the rectosigmoid region. Endoscopic characteristics of hamartomas were indistinguishable from adenomas. CONCLUSIONS: Colonic hamartomas in adults are rare. They tend to be single, pedunculated, and localized predominantly in the rectosigmoid region. Endoscopic resection of colonic hamartomas was successful in all patients.


Asunto(s)
Enfermedades del Colon/diagnóstico , Hamartoma/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Enfermedades del Colon/complicaciones , Enfermedades del Colon/patología , Enfermedades del Colon/cirugía , Pólipos del Colon/complicaciones , Pólipos del Colon/patología , Colonoscopía , Femenino , Hamartoma/complicaciones , Hamartoma/patología , Hamartoma/cirugía , Humanos , Masculino , Persona de Mediana Edad
14.
Regul Pept ; 119(3): 163-7, 2004 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-15120476

RESUMEN

BACKGROUND AND AIMS: Transforming growth alpha (TGFalpha) and sensory neurons have been shown to promote gastric mucosal protection and healing. Aims were to examine in vitro interactions between gastric sensory neurons, the sensory neuropeptide calcitonin gene-related peptide (CGRP), and TGFalpha. METHODS: Gastric mucosal/submucosal tissue fragments from Sprague-Dawley (SD) rats were incubated in short-term (30 min) culture. Peptide release into media and TGFalpha tissue content were measured by radioimmunoassay. RESULTS: TGFalpha (1 x 10(-8) to 1 x 10(-6) M) caused dose-dependent stimulation of CGRP release. Maximal CGRP release (+87%) was observed with 1 x 10(-6) M TGFalpha: 28.6+/-3.8 vs. control of 15.5+/-2.7 pg/g tissue; P<0.05. Both CGRP (1 x 10(-7) to 1 x 10(-5) M) and capsaicin (1 x 10-(8) to 1 x 10(-6)M) significantly inhibited basal TGFalpha release in a dose-dependent fashion that ranged from -20% to -39%. In contrast, capsaicin-induced sensory denervation caused significant increases in both basal TGFalpha release and TGFalpha tissue content. CONCLUSION: Function interactions between TGFalpha and gastric sensory neurons are suggested by the observations that (1) TGFalpha stimulated CGRP release from gastric sensory neurons; (2) CGRP and acute capsaicin treatment inhibited TGFalpha release and; (3) capsaicin-induced sensory denervation caused significant increases in both gastric TGFalpha basal release and tissue content.


Asunto(s)
Péptido Relacionado con Gen de Calcitonina/metabolismo , Capsaicina/metabolismo , Mucosa Gástrica/metabolismo , Neuronas Aferentes/metabolismo , Factor de Crecimiento Transformador alfa/metabolismo , Animales , Péptido Relacionado con Gen de Calcitonina/farmacología , Relación Dosis-Respuesta a Droga , Mucosa Gástrica/inervación , Técnicas In Vitro , Masculino , Ratas , Ratas Sprague-Dawley , Factor de Crecimiento Transformador alfa/farmacología
15.
Dig Dis Sci ; 49(11-12): 1875-81, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15628719

RESUMEN

gamma-Aminobutyric acid (GABA) is a neurotransmitter found in both the central and the peripheral nervous systems including the gastrointestinal tract. The aims of the present studies were to examine mechanisms by which GABA exerts gastroprotective effects against ethanol- and water-restraint stress (WRS)-induced gastric mucosal injury in the rat. GABA, administered intragastrically (400 mg/kg), induced gastroprotection against ethanol and WRS by activating gastric sensory neurons to release calcitonin gene-related peptide (CGRP) and promote nitric oxide (NO) synthesis and release. Furthermore, these protective effects of GABA were associated with an increase in gastric mucosal blood flow (GMBF) that was dependent on sensory neuron and NO systems. GABA-mediated protection involved GABAA receptor activation and prostaglandin generation. In conclusion, intraluminal GABA protects the stomach against ethanol- and WRS-induced injury by mechanisms which involve sensory neuron/CGRP/NO pathways and increases in GMBF and prostaglandin generation.


Asunto(s)
Neuronas Aferentes/fisiología , Óxido Nítrico/fisiología , Úlcera Gástrica/fisiopatología , Ácido gamma-Aminobutírico/fisiología , Animales , Péptido Relacionado con Gen de Calcitonina/metabolismo , Etanol/antagonistas & inhibidores , Agonistas del GABA/farmacología , Antagonistas del GABA/farmacología , Mucosa Gástrica/irrigación sanguínea , Mucosa Gástrica/efectos de los fármacos , Masculino , Prostaglandinas/fisiología , Ratas , Ratas Sprague-Dawley , Estrés Fisiológico/fisiopatología , Ácido gamma-Aminobutírico/farmacología
16.
Dig Dis Sci ; 48(2): 329-33, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12643611

RESUMEN

The mechanisms by which transforming growth factor-a (TGP-alpha) protects the stomach against mucosal injury are incompletely understood. The aim of this study was to examine the roles of sensory neurons, sensory neuropeptides and prostaglandins in TGFalpha gastroprotection against ethanol. Fasted rats received TGF-alpha (50 microg/kg, intraperitoneally) prior to orogastric ethanol (75% v/v, 1 ml). Gastric injury was quantitated 30 min after ethanol. Involvement of sensory neurons and the sensory neuropeptides, calcitonin gene-related peptide (CGRP) and substance P (SP), were examined by capsaicin deafferentation and specific receptor antagonist infusion, respectively. Indomethacin (10 mg, intragastrically) was used to determine the role of prostaglandins in TGF-alpha-mediated gastroprotection. TGF-alpha significantly diminished ethanol-induced gastric lesion area to 5.7 +/- 0.8 mm2 vs 41.1 +/- 5.2 mm2 (p < 0.001). Sensory denervation and CGRP-receptor blockade abolished the TGF-alpha protective effect. In contrast, SP antagonist and indomethacin did not alter TGF-alpha gastroprotection. In conclusion, TGF-alpha-mediated gastroprotection involves sensory neuron activation and CGRP release and this protective effect did not involve substance P or prostaglandin generation.


Asunto(s)
Péptido Relacionado con Gen de Calcitonina/análisis , Capsaicina/farmacología , Mucosa Gástrica/efectos de los fármacos , Mucosa Gástrica/patología , Indometacina/farmacología , Sustancia P/análisis , Factor de Crecimiento Transformador alfa/farmacología , Análisis de Varianza , Animales , Modelos Animales de Enfermedad , Etanol , Gastritis/prevención & control , Inyecciones Intraperitoneales , Masculino , Neuronas Aferentes , Neuropéptidos/análisis , Probabilidad , Prostaglandinas/análisis , Cintigrafía , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Valores de Referencia , Sensibilidad y Especificidad , Estómago/diagnóstico por imagen , Estómago/efectos de los fármacos
17.
Life Sci ; 72(16): 1803-11, 2003 Mar 07.
Artículo en Inglés | MEDLINE | ID: mdl-12586218

RESUMEN

Exogenously administered TGF alpha has been shown to protect rodent gastric mucosa against injury caused by acid-dependent and acid-independent injury. The present study examined whether the gastroprotective effects of TGF alpha on stress-induced gastric ulceration in the rat involves activation of capsaicin-sensitive sensory neurons. Fasted male SD rats were subjected to water restraint stress (WRS) for four hours. Thereafter, rats were euthanized; the stomach opened and macroscopic areas of gastric ulceration quantitated (mm(2)). Gastric tissue contents of TGF alpha and the sensory neuropeptide, calcitonin gene-related peptide (CGRP) were determined by radioimmunoassay. Prior to stress rats received TGF alpha 50, 100 or 200 microg/kg by intraperitoneal injection. Sensory denervation was accomplished by high dose capsaicin treatment. WRS caused severe ulceration in the gastric corpus; 46.1 + 6.6 mm(2). Parenteral administration of TGF alpha caused dose-dependent reduction in gastric injury: 34.7 + 4.9 mm(2) with 50 microg/kg (p < 0.05); 25.4 + 3.6 mm(2) with 100 microg/kg (p < 0.001) and 9.4 + 0.8 mm(2) with 200 microg/kg (p < 0.001). The gastroprotective action of TGF alpha (200 microg/kg, i.p.) was abolished by capsaicin-induced sensory denervation. In addition, WRS ulceration was associated with significant reduction in gastric CGRP (-42%) and TGF alpha (-48%) content. Reduction in CGRP content was prevented by TGF alpha pretreatment. We conclude that: 1) TGF alpha caused dose-dependent gastroprotection against WRS ulceration, 2) TGF alpha-mediated gastric mucosal protection was prevented by capsaicin-induced sensory denervation and, 3) stress-induced injury was associated with significant reduction in gastric content of both TGF alpha and CGRP.


Asunto(s)
Capsaicina/metabolismo , Mucosa Gástrica/inervación , Neuronas Aferentes/fisiología , Úlcera Gástrica/prevención & control , Factor de Crecimiento Transformador alfa/uso terapéutico , Animales , Péptido Relacionado con Gen de Calcitonina/metabolismo , Relación Dosis-Respuesta a Droga , Mucosa Gástrica/metabolismo , Inmersión , Inmovilización , Inyecciones Intraperitoneales , Masculino , Neuronas Aferentes/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Estómago/efectos de los fármacos , Estómago/inervación , Estómago/patología , Úlcera Gástrica/metabolismo , Úlcera Gástrica/patología , Estrés Psicológico , Simpatectomía Química , Factor de Crecimiento Transformador alfa/metabolismo
18.
Regul Pept ; 110(2): 107-13, 2003 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-12527143

RESUMEN

BACKGROUND/AIMS: The mechanisms of somatostatin-mediated gastroprotection are not fully understood. Aims of this study were to determine in the rat the role of nitric oxide (NO) in somatostatin-induced effects on gastric mucosal protection and blood flow (GMBF) in the absence and in the presence of intraluminal ethanol. METHODS: Ethanol (70% v/v)-induced gastric mucosal injury after orogastric dosing was quantitated at 30 min and GMBF determined in an ex vivo gastric chamber preparation. RESULTS: Somatostatin (4 microg/kg; i.p.) protection against ethanol-induced ulceration was prevented by the NO inhibitor L-NNA and restored by L-arginine, but not D-arginine. Somatostatin (1-8 microg/kg; i.p.) did not effect basal GMBF. The gastroprotective dose of somatostatin (4 microg/kg; i.p.) prevented the decrease in GMBF caused by ethanol. L-NNA reversed this vascular effect of somatostatin. CONCLUSION: Somatostatin-induced gastroprotection and restoration of GMBF during ethanol exposure involve mechanisms which are dependent on NO generation.


Asunto(s)
Etanol/toxicidad , Mucosa Gástrica/irrigación sanguínea , Mucosa Gástrica/efectos de los fármacos , Óxido Nítrico/metabolismo , Somatostatina/farmacología , Administración Oral , Animales , Arginina/farmacología , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Péptido Relacionado con Gen de Calcitonina/efectos de los fármacos , Péptido Relacionado con Gen de Calcitonina/metabolismo , Inhibidores Enzimáticos/farmacología , Etanol/administración & dosificación , Mucosa Gástrica/metabolismo , Masculino , Donantes de Óxido Nítrico/farmacología , Nitroarginina/farmacología , Ratas , Ratas Sprague-Dawley
19.
J Okla State Med Assoc ; 96(11): 519-21, 2003 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-14699653

RESUMEN

Primary aortoenteric fistula (PAEF) is a well-known but rare cause of gastrointestinal bleeding. The diagnosis can be difficult since the majority of patients do not have classical symptoms. "Herald bleed" is usually followed by a massive hemorrhage. Endoscopy and radiographic studies can assist in diagnosis. We present the case of 56-year-old male with PAEF who presented with obscure gastrointestinal bleeding. Endoscopic studies were unremarkable. Computed tomography (CT) in this stable but symptomatic patient helped in establishing diagnosis of PAEF. Patient underwent laparotomy with aortobifemoral graft placement. A high index of suspicion, early diagnosis and prompt appropriate surgical intervention are crucial for survival of these patients.


Asunto(s)
Aneurisma de la Aorta Abdominal/complicaciones , Fístula/complicaciones , Hemorragia Gastrointestinal/etiología , Fístula Intestinal/complicaciones , Enfermedades del Yeyuno/complicaciones , Aneurisma de la Aorta Abdominal/diagnóstico por imagen , Hemorragia Gastrointestinal/diagnóstico por imagen , Humanos , Laparotomía , Masculino , Persona de Mediana Edad , Tomografía Computarizada por Rayos X
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA